Determinants of vascular impairment in type 1 diabetes-impact of sex and connexin 37 gene polymorphism: A cross-sectional study
Jazyk angličtina Země Anglie, Velká Británie Médium electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NU20-01-00083
Ministry of Health of the Czech Republic
NU20-01-00083
Ministry of Health of the Czech Republic
NU20-01-00083
Ministry of Health of the Czech Republic
NU20-01-00083
Ministry of Health of the Czech Republic
LX22NPO5104
National Institute for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES) unded by the European Union- Next Generation EU and by Ministry of Health of the Czech Republic
PubMed
39175027
PubMed Central
PMC11342627
DOI
10.1186/s12933-024-02401-0
PII: 10.1186/s12933-024-02401-0
Knihovny.cz E-zdroje
- Klíčová slova
- Cardiovascular risk factors, Gene for connexin 37, Sex, Type 1 diabetes mellitus, Vascular parameters,
- MeSH
- diabetes mellitus 1. typu * genetika patofyziologie MeSH
- diabetické angiopatie genetika patofyziologie MeSH
- dospělí MeSH
- fenotyp MeSH
- fotopletysmografie MeSH
- genetická predispozice k nemoci MeSH
- hodnoty glomerulární filtrace MeSH
- intimomediální šíře tepenné stěny MeSH
- lidé středního věku MeSH
- lidé MeSH
- polymorfismus genetický MeSH
- protein alfa 4 mezerového spoje * genetika MeSH
- průřezové studie MeSH
- rizikové faktory kardiovaskulárních chorob MeSH
- sexuální faktory MeSH
- tlakový index kotník-paže MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- gap junction protein alpha 4, human MeSH Prohlížeč
- protein alfa 4 mezerového spoje * MeSH
BACKGROUND: The associations of risk factors with vascular impairment in type 1 diabetes patients seem more complex than that in type 2 diabetes patients. Therefore, we analyzed the associations between traditional and novel cardiovascular risk factors and vascular parameters in individuals with T1D and modifications of these associations according to sex and genetic factors. METHODS: In a cross-sectional study, we analyzed the association of risk factors in T1D individuals younger than 65 years using vascular parameters, such as ankle brachial index (ABI) and toe brachial index (TBI), duplex ultrasound, measuring the presence of plaques in carotid and femoral arteries (Belcaro score) and intima media thickness of carotid arteries (CIMT). We also used photoplethysmography, which measured the interbranch index expressed as the Oliva-Roztocil index (ORI), and analyzed renal parameters, such as urine albumin/creatinine ratio (uACR) and glomerular filtration rate (GFR). We evaluated these associations using multivariate regression analysis, including interactions with sex and the gene for connexin 37 (Cx37) polymorphism (rs1764391). RESULTS: In 235 men and 227 women (mean age 43.6 ± 13.6 years; mean duration of diabetes 22.1 ± 11.3 years), pulse pressure was strongly associated with unfavorable values of most of the vascular parameters under study (ABI, TBI, Belcaro scores, uACR and ORI), whereas plasma lipids, represented by remnant cholesterol (cholesterol - LDL-HDL cholesterol), the atherogenic index of plasma (log (triglycerides/HDL cholesterol) and Lp(a), were associated primarily with renal impairment (uACR, GFR and lipoprotein (a)). Plasma non-HDL cholesterol was not associated with any vascular parameter under study. In contrast to pulse pressure, the associations of lipid factors with kidney and vascular parameters were modified by sex and the Cx37 gene. CONCLUSION: In addition to known information, easily obtainable risk factor, such as pulse pressure, should be considered in individuals with T1D irrespective of sex and genetic background. The associations of plasma lipids with kidney function are complex and associated with sex and genetic factors. The decision of whether pulse pressure, remnant lipoproteins, Lp(a) and other determinants of vascular damage should become treatment targets in T1D should be based on the results of future clinical trials.
Department of Cardiology Institute for Clinical and Experimental Medicine Prague Czech Republic
Department of Geriatric Internal Medicine 2nd Medical Faculty Motol Prague Czech Republic
Faculty of Mathematics and Physics Charles University Prague Prague Czech Republic
Institute of Computer Science Czech Academy of Sciences Prague Czech Republic
Zobrazit více v PubMed
Zhao Y, Quan E, Zeng T, Huang Z, Luo Y, Peng L, et al. Type 1 diabetes, its complications, and non-ischemic cardiomyopathy: a mendelian randomization study of European ancestry. Cardiovasc Diabetol. 2024;23(1):31. 10.1186/s12933-023-02117-7 PubMed DOI PMC
Wei J, Tian J, Tang C, Fang X, Miao R, et al. The Influence of Different Types of Diabetes on Vascular Complications. J Diabetes Res. 2022;2022:3448618. 10.1155/2022/3448618. 10.1155/2022/3448618 PubMed DOI PMC
Ruiz PLD, Chen L, Morton JI, Salim A, Carstensen B, Gregg EW, et al. Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts. Diabetologia. 2022;65(6):964–72. 10.1007/s00125-022-05659-9 PubMed DOI PMC
Piťhová P, Štechová K, Piťha J, Lánská V, Kvapil M. Determinants of preclinical atherosclerosis are different in type 1 and type 2 diabetic women. Physiol Res. 2016;65(2):219–28. 10.33549/physiolres.933019 PubMed DOI
Liu Z, Wang H, Yang Z, Lu Y, Zou C. Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a mendelian randomization study. Cardiovasc Diabetol. 2023;22(1):236. 10.1186/s12933-023-01974-6 PubMed DOI PMC
Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Diabetes Control and Complications Trial Research Group, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86. 10.1056/NEJM199309303291401 PubMed DOI
Budoff MJ, Raggi P, Beller GA, Berman DS, Druz RS, Malik S, et al. For the Imaging Council of the American College of Cardiology. Noninvasive cardiovascular risk assessment of the asymptomatic diabetic patient: the Imaging Council of the American College of Cardiology. J Am Coll Cardiol Img. 2016;9:176–92.10.1016/j.jcmg.2015.11.011 PubMed DOI PMC
Helleputte S, Van Bortel L, Verbeke F, Op ‘t Roodt J, Calders P, Lapauw B, De Backer T. Arterial stiffness in patients with type 1 diabetes and its comparison to cardiovascular risk evaluation tools. Cardiovasc Diabetol. 2022;21(1):97. 10.1186/s12933-022-01537-1 PubMed DOI PMC
Bogusz-Górna K, Polańska A, Dańczak-Pazdrowska A, Żaba R, Sumińska M, Fichna P, et al. Non-invasive detection of early microvascular changes in juveniles with type 1 diabetes. Cardiovasc Diabetol. 2023;22(1):285. 10.1186/s12933-023-02031-y PubMed DOI PMC
De Biasio MJ, Furman M, Clarke A, Hui W, Elia Y, Baranger J, et al. Abnormal vascular thickness and stiffness in young adults with type 1 diabetes: new insights from cutting-edge ultrasound modalities. Cardiovasc Diabetol. 2024;23(1):178. 10.1186/s12933-024-02280-5 PubMed DOI PMC
Sun JK, Keenan HA, Cavallerano JD, Asztalos BF, Schaefer EJ, Sell DR, et al. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care. 2011;34(4):968–74. 10.2337/dc10-1675 PubMed DOI PMC
Piťha J, Hubáček JA, Piťhová P. The connexin 37 (1019C > T) gene polymorphism is associated with subclinical atherosclerosis in women with type 1 and 2 diabetes and in women with central obesity. Physiol Res. 2010;59(6):1029–32. 10.33549/physiolres.932039 PubMed DOI
Pitha J, Hubácek JA, Cífková R, Skodová Z, Stávek P, Lánská V, et al. The association between subclinical atherosclerosis in carotid arteries and Connexin 37 gene polymorphism (1019C > T; Pro319Ser) in women. Int Angiol. 2011;30(3):221–6. PubMed
Huxley RR, Peters SAE, Mishra GD, Woodward M. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3(3):198–206. 10.1016/S2213-8587(14)70248-7 PubMed DOI
Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49(4):626–32. 10.2337/diabetes.49.4.626 PubMed DOI
Dobiásová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apob-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583–8. 10.1016/S0009-9120(01)00263-6 PubMed DOI
Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. CKD-EPI investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–9. 10.1056/NEJMoa1114248 PubMed DOI PMC
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. 10.1093/nar/16.3.1215 PubMed DOI PMC
Oliva I, Ipser J, Roztočil K, Guttenbergerová K. Fourier analysis of the pulse wave in obliterating arteriosclerosis. Vasa. 1976;5:95–100. PubMed
Oliva I, Roztočil K. Pulse wave analysis in obliterating atherosclerosis. Angiology. 1983;34:610–9. 10.1177/000331978303400906 PubMed DOI
Přibil J, Přibilová A, Frollo I, First-Step PPG. Signal Analysis for Evaluation of Stress Induced during scanning in the Open-Air MRI device. Sens (Basel). 2020;20(12):3532.10.3390/s20123532 PubMed DOI PMC
Belcaro G, Nicolaides AN, Laurora G, Cesarone AL, et al. Ultrasound morphology classification of the arterial Wall and Cardiovascular events in a 6-Year follow-up study. Arterioscler Thromb Vasc Biol. 1996;16(7):851–6. 10.1161/01.ATV.16.7.851 PubMed DOI
Chambers JM. In: Chambers S, Hastie TJ, editors. Linear models. Chapter 4 of statistical models. Wadsworth & Brooks/Cole; 1992.
Agresti A. Categorical Data. 2nd ed. Wiley; 2002.
Zeileis A, Köll S, Graham N. Various versatile variances: an object-oriented implementation of clustered covariances in R. J Stat Softw. 2020;95(1):1–36. 10.18637/jss.v095.i01.10.18637/jss.v095.i01 DOI
Zeileis A. Econometric Computing with HC and HAC Covariance Matrix estimators. J Stat Softw. 2004;11(10):1–17.10.18637/jss.v011.i10 DOI
R Core Team. R: a Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2023.
Venables WN, Ripley BD. Modern Applied Statistics with S. Fourth Edition. New York: Springer; 2002. ISBN 0-387-95457-0.
Rawshani A, Rawshani A, Sattar N, Franzén S, McGuire DK, Eliasson B, et al. Relative prognostic importance and optimal levels of risk factors for Mortality and Cardiovascular outcomes in type 1 diabetes Mellitus. Circulation. 2019;139(16):1900–12. 10.1161/CIRCULATIONAHA.118.037454 PubMed DOI
Varbo A, Nordestgaard BG. Remnant cholesterol and Triglyceride-Rich Lipoproteins in atherosclerosis progression and Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2016;36(11):2133–5. 10.1161/ATVBAHA.116.308305 PubMed DOI
Rönnback M, Fagerudd J, Forsblom C, Pettersson-Fernholm K, Reunanen A, Groop PH. Finnish Diabetic Nephropathy (FinnDiane) Study Group. Altered age-related blood pressure pattern in type 1 diabetes. Circulation. 2004;110(9):1076–82. 10.1161/01.CIR.0000139903.29522.8D PubMed DOI
Ferreira I, Hovind P, Schalkwijk CG, Parving HH, Stehouwer CDA, Rossing P. Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20year life-course study in an inception cohort. Diabetologia. 2018;61(1):231–41. 10.1007/s00125-017-4470-5 PubMed DOI PMC
Schram MT, Chaturvedi N, Fuller JH, Stehouwer CD, EURODIAB Prospective Complications Study Group. Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the Eurodiab prospective complications study. J Hypertens. 2003;21(11):2035–44. 10.1097/00004872-200311000-00012 PubMed DOI
Glynn RJ, Chae CU, Guralnik JM, Taylor JO, Hennekens CH. Pulse pressure and mortality in older people. Arch Intern Med. 2000;160(18):2765–72. 10.1001/archinte.160.18.2765 PubMed DOI
Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European atherosclerosis society consensus statement. Eur Heart J. 2022;43(39):3925–46. 10.1093/eurheartj/ehac361 PubMed DOI PMC
Mitrofanova A, Burke G, Merscher S, Fornoni A. New insights into renal lipid dysmetabolism in diabetic kidney disease. World J Diabetes. 2021;12(5):524–40. 10.4239/wjd.v12.i5.524 PubMed DOI PMC
Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, et al. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care. 2007;30(10):2523–8. 10.2337/dc07-0282 PubMed DOI
Lan NSR, Bell DA, Watts GF, Fegan PG. Lipid-lowering therapies and cardiovascular risk-stratification strategies in adults with type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2023;30(2):103–12. 10.1097/MED.0000000000000790 PubMed DOI
Nwosu BU, Parajuli S, Khatri K, Jasmin G, Al-Halbouni L, Lee AF. Partial clinical remission reduces lipid-based Cardiovascular risk in adult patients with type 1 diabetes. Front Endocrinol (Lausanne). 2021;12:705565. 10.3389/fendo.2021.705565 PubMed DOI PMC
Tougaard NH, Hansen TW, Rossing P. Vitamin D deficiency and development of complications in individuals with type 1 and type 2 diabetes: a cohort study. J Diabetes Complications. 2023;37(10):108611. 10.1016/j.jdiacomp.2023.108611 PubMed DOI
Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135–43. 10.1161/hc0902.104353 PubMed DOI
Mariaca K, Serés-Noriega T, Viñals C, Perea V, Conget I, Mesa A, et al. Neutrophil-to-lymphocyte ratio is independently associated with carotid atherosclerosis burden in individuals with type 1 diabetes. Nutr Metab Cardiovasc Dis. 2024;34(2):395–403. 10.1016/j.numecd.2023.09.017 PubMed DOI
Chung GE, Jeong SM, Yu SJ, Yoo JJ, Cho Y, Lee KN, et al. Gamma-Glutamyl transferase and the risk of all-cause and disease-specific mortality in patients with diabetes: a nationwide cohort study. J Diabetes. 2024;16(5):e13551. 10.1111/1753-0407.13551 PubMed DOI PMC
Kunovic B, Straus B, Cepelak I. Multiple forms of gamma-glutamyltransferase and lipoproteins. Z Med Lab Diagn. 1990;31(5):284–9. PubMed
Mantovani A, Morieri ML, Palmisano L, Masulli M, Cossu E, Baroni MG, et al. Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus. Cardiovasc Diabetol. 2023;22(1):204. 10.1186/s12933-023-01945-x PubMed DOI PMC
Martínez D, Castro A, Merino PM, López P, Lardone MC, Iñiguez G, et al. Oestrogen activity of the serum in adolescents with type 1 diabetes. Diabet Med. 2016;33(10):1366–73. 10.1111/dme.13078 PubMed DOI
Ahmed B, Bairey Merz CN, Johnson BD, Bittner V, Berga SL, Braunstein GD, WISE Study Group, et al. Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study). Am J Cardiol. 2008;102(2):150–4. 10.1016/j.amjcard.2008.03.029 PubMed DOI PMC
Simon AB, Derella CC, Blackburn M, Thomas J, Layman LC, Nicholson MS, et al. Endogenous estradiol contributes to vascular endothelial dysfunction in premenopausal women with type 1 diabetes. Cardiovasc Diabetol. 2023;22(1):243. 10.1186/s12933-023-01966-6 PubMed DOI PMC
Meens MJ, Pfenniger A, Kwak BR, Delmar M. Regulation of cardiovascular connexins by mechanical forces and junctions. Cardiovasc Res. 2013;99(2):304–14. 10.1093/cvr/cvt095 PubMed DOI PMC
Hautefort A, Pfenniger A, Kwak BR. Endothelial connexins in vascular function. Vasc Biol. 2019;1(1):H117–24. 10.1530/VB-19-0015 PubMed DOI PMC
Wadström BN, Pedersen KM, Wulff AB, Nordestgaard BG. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study. Diabetologia. 2023;66(12):2238–49. 10.1007/s00125-023-06016-0 PubMed DOI PMC
Littmann K, Wodaje T, Alvarsson M, Bottai M, Eriksson M, Parini P, et al. The Association of Lipoprotein(a) plasma levels with prevalence of Cardiovascular Disease and Metabolic Control Status in patients with type 1 diabetes. Diabetes Care. 2020;43(8):1851–8. 10.2337/dc19-1398 PubMed DOI
Wen D, Du X, Nie SP, Dong JZ, Ma CS. Association of Connexin37 C1019T with myocardial infarction and coronary artery disease: a meta-analysis. Exp Gerontol. 2014;58:203–7. 10.1016/j.exger.2014.06.011 PubMed DOI